Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
31.37
-0.29 (-0.92%)
At close: Jul 10, 2025, 4:00 PM
31.94
+0.57 (1.82%)
Pre-market: Jul 11, 2025, 7:22 AM EDT
Harrow Employees
Harrow had 382 employees as of December 31, 2024. The number of employees increased by 67 or 21.27% compared to the previous year.
Employees
382
Change (1Y)
67
Growth (1Y)
21.27%
Revenue / Employee
$557,220
Profits / Employee
-$56,796
Market Cap
1.15B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
HROW News
- 1 day ago - Harrow: Immense Upside Potential - Seeking Alpha
- 4 days ago - HROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 23 days ago - Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications - Business Wire
- 27 days ago - I Am Swimming In Dividends With +7% Yields - Seeking Alpha
- 4 weeks ago - Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals - Business Wire
- 6 weeks ago - Harrow: Epic Growth & Operating Leverage On Full Display - Seeking Alpha
- 2 months ago - Harrow to Present at Two Investor Conferences in May - Business Wire
- 2 months ago - Harrow, Inc. (HROW) Q1 2025 Earnings Call Transcript - Seeking Alpha